'Hcv infections' diaporamas de présentation

Estimating the Global Burden of HCV Infections Associated with Unsafe Health Care Injections

Estimating the Global Burden of HCV Infections Associated with Unsafe Health Care Injections. Anja Hauri 1 , Gregory Armstrong, 2 Yvan Hutin 1 1. WHO Headquarters, Geneva, Switzerland 2. CDC, Atlanta, GA, USA. Background.

318 views • 20 slides

Achieving WHO Recommendations for HCV Elimination in the Western Pacific Region

Achieving WHO Recommendations for HCV Elimination in the Western Pacific Region. L. Wei April 13, 2016. In 2016, there are approximately 14 million viremic HCV infections in the Western Pacific region (0.7% prevalence). Prevalence (Viremic). 0.0%-0.6%. 0.6%-0.8%. 0.8%-1.3%. 1.3%-2.9%.

144 views • 14 slides

Injection Drug Use and Hepatitis C What Can We Do About It?

137 views • 13 slides

Seroprevalance of Hepatitis C in Turkey (%) (Anti-HCV positivity in donors)

Adana (n:8310) Antalya (n:16.410) Bursa (n:16.512) Erzurum (n:24.870) ?stanbul (n:108.000) Trabzon (n:22.300) Ankara (n:14.372). Seroprevalance of Hepatitis C in Turkey (%) (Anti-HCV positivity in donors).

192 views • 10 slides

Seroprevalance of Hepatitis C in Turkey (%) (Anti-HCV positivity in donors)

Adana (n:8310) Antalya (n:16.410) Bursa (n:16.512) Erzurum (n:24.870) ?stanbul (n:108.000) Trabzon (n:22.300) Ankara (n:14.372). Seroprevalance of Hepatitis C in Turkey (%) (Anti-HCV positivity in donors).

203 views • 10 slides

Summary

Are newly diagnosed patients with HBV and HCV infection different ? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver.

169 views • 1 slides